ECIL 3-2009 update guidelines for antifungal management

Bone Marrow Transplantation

Volumn 47, Issue 6, 2012, Pages 866-

  Castagna, L ^a   Bramanti, S ^a   Sarina, B ^a   Todisco, E ^a   Ibatici, A ^a   Santoro, A ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; VORICONAZOLE;

ACUTE LEUKEMIA; DISEASE FREE SURVIVAL; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; LETTER; MEDICAL RESEARCH; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL TIME; SYSTEMIC MYCOSIS;

ANTIFUNGAL AGENTS; HUMANS; LEUKEMIA; MYCOSES;

EID: 84862217239     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.154     Document Type: Letter

References (4)

1. Maertens J, Marchetti O, Herbrecht R, Cornely OA, Flückiger U, Frêre P et al. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: Summary of the ECIL 3-2009 update. Bone Marrow Transplant 2011; 46: 709-718.
2. Wingard JR, Carter SL, Walsh TJ, Kurtzberg J, Small TN, Baden LR et al. Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood 2010; 116: 5111-5118.
3. Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: Overview of the Transplant- Associated Infection Surveillance Network (TRANSNET) database. Clin Infect Dis 2010; 50: 1091-1100.
4. Girmenia C, Barosi G, Aversa F, Bacigalupo A, Barbui T, Baronciani D et al. Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: Results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Clin Infect Dis 2009; 49: 1226-1236.